Biosolution Co.Ltd (086820) — Cash Flow Quality Index

Latest as of December 2023: 0.53x

Biosolution Co.Ltd (086820) has a Cash Flow Quality Index of 0.53x as of December 2023. Operating cash flow of ₩1.96 Billion is below net income of ₩3.74 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 086820 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

0.53x
Operating CF / Net Income

Operating Cash Flow

₩1.96 Billion
KRW

Net Income

₩3.74 Billion
KRW

Data as of

Dec 2023
Most recent filing

Biosolution Co.Ltd Cash Flow Quality Index (2018–2018)

Historical Cash Flow Quality Index for Biosolution Co.Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Biosolution Co.Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Biosolution Co.Ltd (2018–2018)

Year-by-year earnings quality comparison for Biosolution Co.Ltd. For live market cap and the full company financial profile, see Biosolution Co.Ltd market cap and net worth.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2018 0.76x ₩1.03 Billion ₩1.35 Billion
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.